Jeff Jonker

CEO of @ambysmedicines, biotech geek, passionate about helping patients, curious about everything, foodie, U2 fan

[Jeff Jonker @Jeff_Jonker]

We are on the hunt for amazing new team members at #ambysmedicines...come for the science, stay for the people!

[Amanda Valentino @avalentino]

Check out this great role at #ambysmedicines! https://t.co/Ysiq4hqiJw

[Jeff Jonker @Jeff_Jonker]

Wonderful to have @avalentino join the team at @ambysmedicines as our Chief People Officer. Watch out #biotech -- she's coming for your talent! Always on the hunt for amazing new Ambysians: https://t.co/nSIerKcpiC

[Jeff Jonker @Jeff_Jonker]

Excited to announce more amazing talent joining @ambysmedicines: today we welcome Deidre Roniger as our new SVP, Corporate Development & Amanda Valentino as our new Chief People Officer https://t.co/gJtXprBtvF Both superb leaders, serious impact players and awesome new Ambysians!

[Jeff Jonker @Jeff_Jonker]

Awesome. Truth!

[Larry Kim @larrykim]

😂When you finally quit your day job and start your startup
.
.
© Chris Nichols

[Jeff Jonker @Jeff_Jonker]

Don’t know or care what he did but obviously egregious. Bravo to @VertexPharma for upholding their values regardless of seniority. Not done often enough. Gotta walk the talk or values are just words on the wall https://t.co/9d2BnBjrgH

[Jeff Jonker @Jeff_Jonker]

@michael_gilman @Obsidian_Tx Wow! High quality stemware - note to self that might be the edge we've been looking for @ambysmedicines...Congrats on a great deal @michael_gilman and @Obsidian_Tx!

[Jeff Jonker @Jeff_Jonker]

Thanks for the nod @biospace. @ambysmedicines is pursuing groundbreaking science to regenerate the liver. Did I mention we’re hiring? https://t.co/nSIerKcpiC

[BioSpace @biospace]

Top 20 Life Science Startups to Watch in 2019 https://t.co/LI0xNhs3ux

[Jeff Jonker @Jeff_Jonker]

Thrilled to be part of the @ambysmedicines team! Terrific colleagues, bold science, amazing founders, top investors, great partnership, three platforms (traditional, gene and cell therapy approaches) and planning to make liver transplants obsolete. This is going to be fun!

[@ambysmedicines @ambysmedicines]

Ambys Medicines is excited to announce the appointment of Jeff Jonker as President and CEO. Welcome, Jeff! https://t.co/h3aONK1MaJ

[Jeff Jonker @Jeff_Jonker]

I can definitely vouch for one of these books being worth a read! https://t.co/3tPtn7PKzu

[The Chronicle of Philanthropy @Philanthropy]

Books by @johndoerr, @henrytimms and @jeremyheimans, and @KimJonker top the Chronicle’s summer reading list. https://t.co/VutJCEpNJ5

[NGM Bio @NGMBio]

In showing improvement in markers of #fibrosis and #liver function, NGM282 demonstrated a positive effect on PSC patients’ livers that has not previously been seen. #ILC2018

[Stanford Social Innovation Review @SSIReview]

Next week at #SSIRLive: Join experts from Stanford Graduate School of Business on #strategic #concepts that truly matter for #nonprofits. Register now: https://t.co/zNulWRTziX @wfmeehan @KimJonker @KingPhilanthrop @StanfordGSB #business

[Jeff Jonker @Jeff_Jonker]

Terrific to see the enthusiastic reception that Kim and Bill's book Engines of Impact is receiving, including this nod from @mattbish at The @TheEconomist https://t.co/T3TECINDj6

[Matthew Bishop @mattbish]

Want to change the world? Here's what to read. My selection of the best books of 2017 on philanthrocapitalism: https://t.co/7oBf87OXHQ

[Jeff Jonker @Jeff_Jonker]

Well said! Couldn't agree more, but then I'm a touch biased https://t.co/mYxpahqEVW

[Paul Niehaus @PaulFNiehaus]

pre-ordered Engine of Impact because in my experience @wfmeehan and @KimJonker will call a spade a spade

https://t.co/wusf4Mdwii

[Jeff Jonker @Jeff_Jonker]

@CDCGov data are stunning https://t.co/sXppyXGoFi Yes, we need to tackle root causes of #diabetes, but patients also need better medicines https://t.co/JLcEF6Q8UO

[NGM Bio @NGMBio]

'Diabesity' epidemic: @CDCgov says 9.4% of US has #diabetes, 33.9% are pre-diabetic. Our passion: new treatment options #NGMBio

[Jeff Jonker @Jeff_Jonker]

Dr. Steve Harrison presenting NGM Bio's Phase 2 data in NASH at #ilc2017 79% responder rate @ 12wks! All the details https://t.co/MyIKe07qkC

[Jeff Jonker @Jeff_Jonker]

Amen @JohnCendpts, cf. Maraganore/Vagelos: Biopharma has unique social compact. Big $ hikes w/o new value violate it https://t.co/bg0RtB4fNc

[Endpoints News @endpts]

Mylan $MYL is at the center of the latest online maelstrom to erupt over drug pricing... https://t.co/Xoh6dyPzic … by @JohnCendpts

[Jeff Jonker @Jeff_Jonker]

Talk about positive mental outlook! My new mid-year's resolution: be as opportunistically optimistic as @atulbutte https://t.co/Je9Lz4cuzD

[Atul Butte (In Memoriam) @atulbutte]

Flight delayed at @flySFO? Don't just sit there! Visit every @United gate (60s-90s) and you'll gain 3600-4000 steps in 40 minutes!

[Jeff Jonker @Jeff_Jonker]

@DShaywitz I think I just climbed in the ring with a heavyweight champion after taunting him

[Jeff Jonker @Jeff_Jonker]

Excited to have the entire NGM team under one roof again soon! #meetingsattheespressomachine https://t.co/SzplFreyFo

[Ron Leuty @rleuty_biotech]

Look who's moving in to an 8-year-old bldg never occupied by lessee Amgen https://t.co/o4SGFg32fE $AMGN

[Jeff Jonker @Jeff_Jonker]

@michael_gilman Awesome! Pretty sure that my parents are responsible for about half my LinkedIn profile views